mRNA-1273.214

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-1273.214, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants [Phase 2]

See pricing